Lantern Pharma Inc. Lessee, Operating Lease, Liability, to be Paid, Year One
Lantern Pharma Inc. (LTRN) had Lessee, Operating Lease, Liability, to be Paid, Year One of $54.74 thousand as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2025-11-12
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $54.74K.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $54.74K.
- 2025-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $54.74K.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $205.31K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-09-30 | $54.74K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $54.74K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $54.74K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $205.31K 10-K · filed 2025-03-27 |
| 2024-09-30 | $205.31K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $140.22K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $62.45K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $184.53K 10-K · filed 2024-03-18 |
| 2023-09-30 | $184.53K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $184.53K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $134.12K 10-Q · filed 2023-05-09 |
| 2022-09-30 | $53.40K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $53.40K 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |